Agenus AGEN
NASDAQ AGEN
$8.32 +0.09 (+1.03%)
As of: Sep 4, 2026 · 1:37 PM EDT

Agenus (AGEN) Cash from Financing Activities (2010 - 2026)

Agenus (AGEN) posted quarterly Cash from Financing Activities of -$993000.0 for Q1 2026, down 127.63% year-over-year from $3.6 million in Q1 2025, and down 106.46% quarter-over-quarter from $15.4 million in Q4 2025.

Analysis

Agenus (AGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Agenus' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$993000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 127.63% year-over-year to -$993000.0; the TTM figure through Mar 2026 stood at $32.0 million (down 71.32% YoY), while the FY2025 annual figure was $36.6 million, down 70.21% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$993000.0, down from $15.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $79.1 million in Q2 2024, with the low at -$993000.0 in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $16.0 million (2022), against an average of $22.0 million.
  • The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities jumped 250.73% in 2023, then sank 127.63% in 2026.
  • Agenus' Cash from Financing Activities stood at $23.8 million in 2022, then plunged by 69.23% to $7.3 million in 2023, then surged by 233.15% to $24.4 million in 2024, then sank by 36.91% to $15.4 million in 2025, then slumped by 106.46% to -$993000.0 in 2026.
  • Business Quant data shows AGEN's Cash from Financing Activities at -$993000.0 in Q1 2026, $15.4 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 14.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 2.42 Bn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -6.05 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 36.24 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -273.15 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 27.18 Mn
10 Agenus 344.35 Mn 344.35 Mn 34.52 Mn 14.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.68 Mn
Mar 31, 2026 -993,000.00
Dec 31, 2025 15.37 Mn
Sep 30, 2025 6.68 Mn
Jun 30, 2025 10.94 Mn
Mar 31, 2025 3.59 Mn
Dec 31, 2024 24.37 Mn
Sep 30, 2024 4.56 Mn
Jun 30, 2024 79.08 Mn
Mar 31, 2024 14.83 Mn
Dec 31, 2023 7.32 Mn
Sep 30, 2023 18.04 Mn
Jun 30, 2023 38.26 Mn
Mar 31, 2023 56.25 Mn
Dec 31, 2022 23.77 Mn
Sep 30, 2022 28.22 Mn
Jun 30, 2022 27.80 Mn
Mar 31, 2022 16.04 Mn
Dec 31, 2021 71.61 Mn
Sep 30, 2021 78.91 Mn